WRBY Form 144: Proposed 6,000-Share Sale via Morgan Stanley

Rhea-AI Filing Summary

Warby Parker Inc. (WRBY) submitted a Form 144 reporting a proposed sale of 6,000 shares of common stock with an aggregate market value of $141,337.80. The notice names Morgan Stanley Smith Barney LLC as the broker and lists the approximate date of sale as 08/11/2025 on the NYSE.

The filing shows the shares were acquired as restricted stock from the issuer on 06/10/2025 (payment dated 06/10/2025). The form reports 121,958,482 shares outstanding and states there were no securities sold in the past three months. The filer also represents they do not know of any undisclosed material adverse information regarding the issuer.

Insights

Financial Analyst

TL;DR: Form 144 discloses a proposed sale of 6,000 WRBY restricted shares with transaction details and limited scale documented.

The filing provides the core transaction details investors need: class (common), quantity (6,000 shares), aggregate market value ($141,337.80), broker (Morgan Stanley Smith Barney LLC), exchange (NYSE) and an approximate sale date (08/11/2025). It also records acquisition as restricted stock from the issuer on 06/10/2025 and shows the total shares outstanding (121,958,482). On its face, the notice is a routine insider sale disclosure that documents compliance with Rule 144.

Corporate Governance Expert

TL;DR: Insider disclosure shows restricted shares being offered through a broker; the filer attests to no undisclosed material adverse information.

The Form 144 includes the seller's representation that they are unaware of any material adverse, nonpublic information about the issuer, and it records that no related sales occurred in the prior three months. The filing captures provenance of the shares (restricted stock issued and paid on 06/10/2025) and identifies the executing broker, supporting regulatory transparency around an insider disposition.

Form 144 Filer Information	UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 Form 144 NOTICE OF PROPOSED SALE OF SECURITIES PURSUANT TO RULE 144 UNDER THE SECURITIES ACT OF 1933
FORM 144

144: Filer Information

Filer CIK
Filer CCC
Is this a LIVE or TEST Filing?	LIVE TEST
Submission Contact Information
Name
Phone
E-Mail Address

144: Issuer Information

Name of Issuer

SEC File Number

Address of Issuer

Phone

Name of Person for Whose Account the Securities are To Be Sold

See the definition of "person" in paragraph (a) of Rule 144. Information is to be given not only as to the person for whose account the securities are to be sold but also as to all other persons included in that definition. In addition, information shall be given as to sales by all persons whose sales are required by paragraph (e) of Rule 144 to be aggregated with sales for the account of the person filing this notice.

Relationship to Issuer

144: Securities Information

Title of the Class of Securities To Be Sold	Name and Address of the Broker	Number of Shares or Other Units To Be Sold	Aggregate Market Value	Number of Shares or Other Units Outstanding	Approximate Date of Sale	Name the Securities Exchange
Common	Morgan Stanley Smith Barney LLC Executive Financial Services 1 New York Plaza 8th Floor New York NY 10004	6000	141337.80	121958482	08/11/2025	NYSE

Furnish the following information with respect to the acquisition of the securities to be sold and with respect to the payment of all or any part of the purchase price or other consideration therefor:

144: Securities To Be Sold

Title of the Class	Date you Acquired	Nature of Acquisition Transaction	Name of Person from Whom Acquired	Is this a Gift?	Date Donor Acquired	Amount of Securities Acquired	Date of Payment	Nature of Payment *
Common	06/10/2025	Restricted Stock	Issuer			6000	06/10/2025	Not Applicable

* If the securities were purchased and full payment therefor was not made in cash at the time of purchase, explain in the table or in a note thereto the nature of the consideration given. If the consideration consisted of any note or other obligation, or if payment was made in installments describe the arrangement and state when the note or other obligation was discharged in full or the last installment paid.

Furnish the following information as to all securities of the issuer sold during the past 3 months by the person for whose account the securities are to be sold.

144: Securities Sold During The Past 3 Months

Nothing to Report

144: Remarks and Signature

Remarks

Date of Notice

ATTENTION:

The person for whose account the securities to which this notice relates are to be sold hereby represents by signing this notice that he does not know any material adverse information in regard to the current and prospective operations of the Issuer of the securities to be sold which has not been publicly disclosed. If such person has adopted a written trading plan or given trading instructions to satisfy Rule 10b5-1 under the Exchange Act, by signing the form and indicating the date that the plan was adopted or the instruction given, that person makes such representation as of the plan adoption or instruction date.

Signature

ATTENTION: Intentional misstatements or omission of facts constitute Federal Criminal Violations (See 18 U.S.C. 1001)

FAQ

What does the WRBY Form 144 report?

The form reports a proposed sale of 6,000 common shares with aggregate market value of $141,337.80, to be executed via Morgan Stanley Smith Barney LLC.

When is the approximate sale date listed on the WRBY Form 144?

The filing lists the approximate date of sale as 08/11/2025.

How were the shares being sold acquired according to the filing?

The shares were acquired as restricted stock from the issuer on 06/10/2025, with payment dated 06/10/2025.

How many WRBY shares are outstanding per the filing?

The Form 144 shows 121,958,482 shares outstanding.

Were any WRBY securities sold by the filer in the past three months?

The filing states Nothing to Report for securities sold during the past three months.

Does the filer make any attestation about material information?

Yes. By signing, the filer represents they do not know of any material adverse information about the issuer that has not been publicly disclosed.